相关实验视频

Updated: Jan 15, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

33.7K

替代的TMA-93版本在早期阿尔茨海默氏病中表现出可比的性能和区分精度

José Enrique Arriola-Infante1,2, Ernesto García-Roldán3, David García-Solís4

  • 1Department of Neurology, Torrecárdenas University Hospital, Almería, Spain.

Journal of Alzheimer's disease : JAD
|October 16, 2025
PubMed
概括

新版本的TMA-93记忆测试显示了与原始测试对早期阿尔茨海默病 (AD) 诊断的同等性能. 这一发现支持在纵向研究中使用TMA-93版本B.

关键词:
阿尔茨海默病的疾病阿尔茨海默病的疾病.另一种形式的替代形式.生物标志物 生物标志物认知 认知 认知记忆 记忆 记忆 记忆 记忆神经心理测试 神经心理测试

更多相关视频

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-145105:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

804
Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test08:07

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on: November 23, 2019

11.7K

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811